Human recombinant interferon alpha-2a inhibits angiogenesis of chick area vasculosa in shell-less culture

International Journal of Microcirculation-Clinical and Experimental

Volumn 16, Issue 4, 1996, Pages 165-169

  Ribatti, D ^a   Vacca, A ^a   Iurlaro, Monica ^a   Ria, R ^a   Roncali, Luisa ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anti angiogenesis; Area vasculosa; Interferon

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT;

ANIMAL; ARTICLE; BLOOD VESSEL; CELL DIVISION; CHICK EMBRYO; COMPARATIVE STUDY; DRUG EFFECT; PRENATAL DEVELOPMENT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD VESSELS; CELL DIVISION; CHICK EMBRYO; ENDOTHELIUM, VASCULAR; INTERFERON ALFA-2A;

EID: 0030180129     PISSN: 01676865     EISSN: None     Source Type: Journal    
DOI: 10.1159/000179169     Document Type: Article

References (29)

1. Folkman J: Angiogcnesis in cancer, vascular, rheumatoid and other disease, Nat Mod 1995: 1:27-31.
2. Maione TE, Sharpe RJ: Development ofangio-gencsis inhibitors for clinical applications, Trends Pharmacol Sci 1990:11:457-461.
3. Ribatti D, Vacca A, licrtossi M, Roncali L: Anti-angiogenesis: A multipurpose therapeutic tool? IntJ Clin Lab Res 1993:23:117-120.
4. Auerbach W, Auerbach R: Angiogcnesis inhibition: A review, Pharmacol Thcr 1993:63:265-311.
5. Muller G, Behrens J, Nussbaumer U, Bohlen P, Birchmeier W: Inhibitory action of transforming growth factor (1 on endothelial cells, Proc Natl Acad Sci USA 1987;84:5600-5604.
6. Frater-Schroeder M, Risau W, Hallman R, Gautsch R, Bohlen P: Tumor necrosis factor typc-u, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo, Proc Natl Acad Sci USA 1987;84:5277-5281.
7. Sidky YA, Borden EC: Inhibition ofangiogcnc-sis by interferons: Effects on tumor- and lymphocyte-induced vascular responses, Cancer Res 1987;47:5155-5161.
8. Ferrara N, Winer J, Henzel WJ: Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitory factor, Proc Natl Acad Sci USA 1992:89:697-702.
9. Pepper MS, Ferrara N, Orci L, Montesano R: Leukemia inhibitory factor (LIF) inhibits an-giogenesis in vitro, J Cell Sci 1994;108:73-83.
10. White CW, Sondhcimer HM, Crouch EC, Wilson H, Fan LF: Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a, New Engl J Med 1989:320:1197-1200.
11. Orchard PJ, Smith CM, Woods WG, Daly D, Dehner LP, Shapiro R: Treatment of hemangioendotheliomas with alpha interferon, Lancet 1989;ii:567-575.
12. Ezckowitz RAB, Mullikcn JB, Folkman J: Interferon alfa-2a therapy for life-threatening hemangiomas of infancy, New Engl J Med 1992:326:1456-1453.
13. Engler CB, Sander B, Koefocd P, Larsen M, VindingT, Lun-Andcrsen H: Interferon alpha-23 treatment of patients with inffoveal neovas-cular macular degeneration: A pilot investigation, Acta Ophthalmol 1993;71:27-31.
14. Hamburger V, Hamilton HL: A series of normal stages in development of the chick embryo, J Morphol 1951:88:49-92.
15. Auerbach R, Kubai L, Knighton D, Folkman J: A simple procedure for the long-term cultivation of chicken embryos, Dev Biol 1974:41: 391-394.
16. Shuntko JZ, De Fouw DO, Feinberg RN: Vascular histodiffcrcntiation in the chick chorioallantoic membrane: A morphometric study, Anat Rcc 1990;220:179-189.
17. Ribatti D: A morphometric study of the expansion of the chick area vasculosa in shell-less culture, J Anat 1995;186:639-644.
18. Pepper MS, Vassalli JD, Wilks JW, Schweige-rer L, Orci L, Montesano R: Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogcnesis, J Cell Biochem 1994;55:419-434.
19. Cozzolino F, Torcia M, Lucibello M, Morbidcl-li L, Ziche M, Platt J, Fabiani S, Brett J, Stern D: Interfcron-a and interleukin 2 synergistical-ly enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth, J Clin Invest 1993:91:2504-2512.
20. Maheshwari RK, Srikantan V, Bhartiya D, Klcinman HK, Grant DS: Differential effects of interferon gamma and alpha on in vitro model of angiogcnesis, J Cell Physiol 1991:146: 164-169.
21. Pepper MS, Vassalli JD, Orci L, Montesano R: Biphasic effect of transforming growth factor p, on in vitro angiogenesis, Exp Cell Res 1993;204:356-363.
22. Auerbach R, Auerbach W, Polakowski I: Assays for angiogcnesis: A review, Pharmacol Ther 1991:51:1-11.
23. Taylor S, Folkman J: Protamine is an inhibitor of angiogcnesis, Nature 1982:297:307-312.
24. Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K, Havakawa T: Induction of angiogenesis in chick yolk-sac membrane by polv-amines and its inhibition by tissue inhibitors of metalloprotcinascs (TIMP and IIMP;), Biochem Biophys Res Commun 1990; 171:1264-1271.
25. Wright PS, Cross-Docrscn D, Miller JA, Jones WD Bitonti AJ: Inhibition of angiogcnesis in vitro and in ovo with an inhibitor of cellular protein kinases MDL 27032. J Cell Physiol 1992:152:448-457.
26. Romanoff AL: The extraembryonic membranes: in Romanoff AL (ed): The Avian Embryo: Structural and Functional Development, New York, MacMillan, 1960. pp 1039-1141.
27. Quesada JR, Gutterman JU: Interferons in the treatment of human neoplasms, J Interferon Res 1993;9:58-62.
28. Pestka S: Interferon: A decade of accomplishments, foundations of the future in research and therapy, Semin Haematol 1983:23:27-36.
29. Reiter Z: Interferon - A major regulator of natural killer cell-mediated cytotoxicity, J Interferon Res 1993:13:247-257.